Figure 1From: The soluble biomarker calprotectin (a S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumabScatterplots of calprotectin levels with corresponding sum B-mode (BM) or power Doppler (PD) scores. The scatterplots illustrate the distribution of the calprotectin levels with the corresponding total sum B-mode (BM) or power Doppler (PD) scores at baseline and at three months examination.Back to article page